Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
It requires: verifying the chemical compatibility between the peptides (cross-stability), optimizing the ratio to maintain the bioactivity of each component, individual quality control of each peptide before co-formulation, and validating the stability of the lyophilized mixture over time
Partner with Abibba Pharmaa for the PCD and third-party manufacturing business of these nutritional supplements
After, pharmacies, telehealth companies and other health care providers could manufacture copycat GLP-1 therapies
We believe San Diego is a great community to build and grow a high-tech infrastructure and technology company because of the incredible workforcethe ability to attract top talent and draw from world-class universities. Startup honoree La Jolla Labs is tackling one of medicines biggest challenges by developing personalized RNA therapeutics for patients with rare diseasesmany of them children with neurological disorders like ALS
![Cardiovascular disease continuum-GLP-1 action. Adapted from [46]](https://www.researchgate.net/publication/357072789/figure/fig1/AS:1146405179654167@1650335702879/Cardiovascular-disease-continuum-GLP-1-action-Adapted-from-46.png)
